Cargando…
1564MO Characterization of COVID-19 vaccination response by antibody (Ab) titer and T-cell receptor (TCR) sequencing in patients (pts) with advanced genitourinary (GU) cancers
| Autores principales: | , , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
European Society for Medical Oncology. Published by Elsevier Ltd.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8454399/ http://dx.doi.org/10.1016/j.annonc.2021.08.1557 |
| _version_ | 1784570485119385600 |
|---|---|
| author | Salgia, S.K. Malhotra, J. Zengin, Z. Meza, L. Ely, J. Hsu, J. Kelley, E. Chehrazi-Raffle, A. Govindarajan, A. Muddasani, R. Salgia, N. Dizman, N. Chawla, N. Dorff, T. Lyou, Y. Karczewska, E. Trent, J. Salgia, R. Altin, J. Pal, S.K. |
| author_facet | Salgia, S.K. Malhotra, J. Zengin, Z. Meza, L. Ely, J. Hsu, J. Kelley, E. Chehrazi-Raffle, A. Govindarajan, A. Muddasani, R. Salgia, N. Dizman, N. Chawla, N. Dorff, T. Lyou, Y. Karczewska, E. Trent, J. Salgia, R. Altin, J. Pal, S.K. |
| author_sort | Salgia, S.K. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8454399 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | European Society for Medical Oncology. Published by Elsevier Ltd. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-84543992021-09-21 1564MO Characterization of COVID-19 vaccination response by antibody (Ab) titer and T-cell receptor (TCR) sequencing in patients (pts) with advanced genitourinary (GU) cancers Salgia, S.K. Malhotra, J. Zengin, Z. Meza, L. Ely, J. Hsu, J. Kelley, E. Chehrazi-Raffle, A. Govindarajan, A. Muddasani, R. Salgia, N. Dizman, N. Chawla, N. Dorff, T. Lyou, Y. Karczewska, E. Trent, J. Salgia, R. Altin, J. Pal, S.K. Ann Oncol Article European Society for Medical Oncology. Published by Elsevier Ltd. 2021-09 2021-09-21 /pmc/articles/PMC8454399/ http://dx.doi.org/10.1016/j.annonc.2021.08.1557 Text en Copyright © 2021 European Society for Medical Oncology. Published by Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Article Salgia, S.K. Malhotra, J. Zengin, Z. Meza, L. Ely, J. Hsu, J. Kelley, E. Chehrazi-Raffle, A. Govindarajan, A. Muddasani, R. Salgia, N. Dizman, N. Chawla, N. Dorff, T. Lyou, Y. Karczewska, E. Trent, J. Salgia, R. Altin, J. Pal, S.K. 1564MO Characterization of COVID-19 vaccination response by antibody (Ab) titer and T-cell receptor (TCR) sequencing in patients (pts) with advanced genitourinary (GU) cancers |
| title | 1564MO Characterization of COVID-19 vaccination response by antibody (Ab) titer and T-cell receptor (TCR) sequencing in patients (pts) with advanced genitourinary (GU) cancers |
| title_full | 1564MO Characterization of COVID-19 vaccination response by antibody (Ab) titer and T-cell receptor (TCR) sequencing in patients (pts) with advanced genitourinary (GU) cancers |
| title_fullStr | 1564MO Characterization of COVID-19 vaccination response by antibody (Ab) titer and T-cell receptor (TCR) sequencing in patients (pts) with advanced genitourinary (GU) cancers |
| title_full_unstemmed | 1564MO Characterization of COVID-19 vaccination response by antibody (Ab) titer and T-cell receptor (TCR) sequencing in patients (pts) with advanced genitourinary (GU) cancers |
| title_short | 1564MO Characterization of COVID-19 vaccination response by antibody (Ab) titer and T-cell receptor (TCR) sequencing in patients (pts) with advanced genitourinary (GU) cancers |
| title_sort | 1564mo characterization of covid-19 vaccination response by antibody (ab) titer and t-cell receptor (tcr) sequencing in patients (pts) with advanced genitourinary (gu) cancers |
| topic | Article |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8454399/ http://dx.doi.org/10.1016/j.annonc.2021.08.1557 |
| work_keys_str_mv | AT salgiask 1564mocharacterizationofcovid19vaccinationresponsebyantibodyabtiterandtcellreceptortcrsequencinginpatientsptswithadvancedgenitourinarygucancers AT malhotraj 1564mocharacterizationofcovid19vaccinationresponsebyantibodyabtiterandtcellreceptortcrsequencinginpatientsptswithadvancedgenitourinarygucancers AT zenginz 1564mocharacterizationofcovid19vaccinationresponsebyantibodyabtiterandtcellreceptortcrsequencinginpatientsptswithadvancedgenitourinarygucancers AT mezal 1564mocharacterizationofcovid19vaccinationresponsebyantibodyabtiterandtcellreceptortcrsequencinginpatientsptswithadvancedgenitourinarygucancers AT elyj 1564mocharacterizationofcovid19vaccinationresponsebyantibodyabtiterandtcellreceptortcrsequencinginpatientsptswithadvancedgenitourinarygucancers AT hsuj 1564mocharacterizationofcovid19vaccinationresponsebyantibodyabtiterandtcellreceptortcrsequencinginpatientsptswithadvancedgenitourinarygucancers AT kelleye 1564mocharacterizationofcovid19vaccinationresponsebyantibodyabtiterandtcellreceptortcrsequencinginpatientsptswithadvancedgenitourinarygucancers AT chehrazirafflea 1564mocharacterizationofcovid19vaccinationresponsebyantibodyabtiterandtcellreceptortcrsequencinginpatientsptswithadvancedgenitourinarygucancers AT govindarajana 1564mocharacterizationofcovid19vaccinationresponsebyantibodyabtiterandtcellreceptortcrsequencinginpatientsptswithadvancedgenitourinarygucancers AT muddasanir 1564mocharacterizationofcovid19vaccinationresponsebyantibodyabtiterandtcellreceptortcrsequencinginpatientsptswithadvancedgenitourinarygucancers AT salgian 1564mocharacterizationofcovid19vaccinationresponsebyantibodyabtiterandtcellreceptortcrsequencinginpatientsptswithadvancedgenitourinarygucancers AT dizmann 1564mocharacterizationofcovid19vaccinationresponsebyantibodyabtiterandtcellreceptortcrsequencinginpatientsptswithadvancedgenitourinarygucancers AT chawlan 1564mocharacterizationofcovid19vaccinationresponsebyantibodyabtiterandtcellreceptortcrsequencinginpatientsptswithadvancedgenitourinarygucancers AT dorfft 1564mocharacterizationofcovid19vaccinationresponsebyantibodyabtiterandtcellreceptortcrsequencinginpatientsptswithadvancedgenitourinarygucancers AT lyouy 1564mocharacterizationofcovid19vaccinationresponsebyantibodyabtiterandtcellreceptortcrsequencinginpatientsptswithadvancedgenitourinarygucancers AT karczewskae 1564mocharacterizationofcovid19vaccinationresponsebyantibodyabtiterandtcellreceptortcrsequencinginpatientsptswithadvancedgenitourinarygucancers AT trentj 1564mocharacterizationofcovid19vaccinationresponsebyantibodyabtiterandtcellreceptortcrsequencinginpatientsptswithadvancedgenitourinarygucancers AT salgiar 1564mocharacterizationofcovid19vaccinationresponsebyantibodyabtiterandtcellreceptortcrsequencinginpatientsptswithadvancedgenitourinarygucancers AT altinj 1564mocharacterizationofcovid19vaccinationresponsebyantibodyabtiterandtcellreceptortcrsequencinginpatientsptswithadvancedgenitourinarygucancers AT palsk 1564mocharacterizationofcovid19vaccinationresponsebyantibodyabtiterandtcellreceptortcrsequencinginpatientsptswithadvancedgenitourinarygucancers |